Cancer Radiotherapie最新文献

{"title":"Erratum to “External beam radiotherapy for prostatic cancers: 2025 update” [Cancer Radiother 29 (2025) 104777]","authors":"Igor Latorzeff , Alizée Camps-Maléa , Christophe Hennequin , Olivier Chapet , David Pasquier , Gilles Créhange , Pascal Pommier , Khémara Gnep , Renaud de Crevoisier , Pierre Blanchard , Ulrike Schick , Vincent Marchesi , Paul Sargos , Stéphane Supiot","doi":"10.1016/j.canrad.2026.104800","DOIUrl":"10.1016/j.canrad.2026.104800","url":null,"abstract":"","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104800"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146215449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiotherapy and brachytherapy in the management of adult soft tissue sarcomas","authors":"Benoît Allignet ,&nbsp;Carmen Llacer ,&nbsp;Anne Ducassou ,&nbsp;Pauline Gillon ,&nbsp;Luc Olivier ,&nbsp;Marie-Pierre Sunyach ,&nbsp;Augustin Mervoyer ,&nbsp;Laurence Moureau-Zabotto ,&nbsp;Marie-Claude Biston ,&nbsp;Juliette Thariat ,&nbsp;Cécile Le Péchoux","doi":"10.1016/j.canrad.2026.104805","DOIUrl":"10.1016/j.canrad.2026.104805","url":null,"abstract":"<div><div>We present the update of the recommendations of the Société française de radiothérapie oncologique (the French society for radiation oncology) on soft tissue sarcomas. Currently, the initial management of sarcomas is very important as it may impact on patients’ quality of life, especially in the case of limb soft tissue sarcomas, and on overall survival in trunk sarcomas. Radiotherapy has to be discussed within a multidisciplinary board meeting with results of biopsy, eventually re-examined by a dedicated sarcoma pathologist. The role of radiotherapy varies according to localization of soft tissue sarcomas; the use of intensity-modulated radiotherapy has become standard of care. It is part of the standard treatment for grade 2 and 3 sarcomas of the extremities and superficial trunk at least 5<!--> <!-->cm. Preoperative radiotherapy is generally preferred to postoperative irradiation in expert soft tissue sarcomas centres. In the case of incomplete resection, re-excision should be discussed. In such cases, radiation may be delivered preoperatively (50<!--> <!-->Gy in 25 fractions of 2<!--> <!-->Gy) or postoperatively. For retroperitoneal sarcomas, preoperative intensity-modulated radiotherapy cannot be proposed systematically following the results of STRASS trial. Concomitant chemoradiotherapy cannot be considered a standard treatment. All other soft tissue sarcomas sites will be addressed as well as as desmoid tumours, and other techniques that may be used such as brachytherapy and proton therapy. Hypofractionated radiotherapy for soft tissue sarcomas has also been adressed.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104805"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147710023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Practice-changing clinical trials in radiation oncology: A 2024–2025 literature synthesis","authors":"Florence Huguet ,&nbsp;Karine Peignaux Casasnovas ,&nbsp;Mario Terlizzi ,&nbsp;Sébastien Thureau ,&nbsp;Jihane Boustani ,&nbsp;Delphine Antoni","doi":"10.1016/j.canrad.2026.104808","DOIUrl":"10.1016/j.canrad.2026.104808","url":null,"abstract":"<div><div>Radiotherapy is constantly evolving, both in terms of technological advances, new therapeutic strategies, and new treatment combinations. Knowledge of the results of the latest clinical trials is essential to benefit patients. The purpose of this work is to respond with the last evidence-based recently presented or published data. Also, this article provides an update on trials that are changing practices in gastrointestinal, urological, gynaecological, breast, and thoracic oncology, as well as in the context of oligometastatic disease.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104808"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147710025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to ‘Radiotherapy and brachytherapy for cervical cancer : Recommendations of the Société française de radiothérapie oncologique’ [Cancer Radiother 29 (2025) 104753]","authors":"Cyrus Chargari ,&nbsp;Anne Ducassou ,&nbsp;Adrien Laville ,&nbsp;François Lucia ,&nbsp;Adeline Petit ,&nbsp;Isabelle Flandin ,&nbsp;Abel Cordoba ,&nbsp;Sophie Renard ,&nbsp;Sylvain Demontoy ,&nbsp;Jean-Michel Hannoun-Lévi ,&nbsp;Carole Lafond ,&nbsp;Alexandre Escande","doi":"10.1016/j.canrad.2026.104799","DOIUrl":"10.1016/j.canrad.2026.104799","url":null,"abstract":"","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104799"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147747154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The French Reirradiation Team for Research and Treatment (FReTREAT): A national collaborative model by Unitrad for advancing reirradiation research, education, and clinical practice in France","authors":"Arnaud Beddok ,&nbsp;Assia Lamrani-Ghaouti ,&nbsp;Luc Delporte ,&nbsp;Myriam Ayadi ,&nbsp;Yazid Belkacemi ,&nbsp;Valentin Calugaru ,&nbsp;Gilles Créhange ,&nbsp;Cyrus Chargari ,&nbsp;Anne-Sophie Dirand ,&nbsp;Pauline Dupuis ,&nbsp;Valentine Guimas ,&nbsp;Jean-Michel Hannoun-Lévi ,&nbsp;Youlia Kirova ,&nbsp;Luc Olliver ,&nbsp;Françoise Mornex ,&nbsp;Georges Noël ,&nbsp;David Pasquier ,&nbsp;Marie-Pierre Sunyach ,&nbsp;Juliette Thariat ,&nbsp;Véronique Vendrely ,&nbsp;Sofia Rivera","doi":"10.1016/j.canrad.2026.104798","DOIUrl":"10.1016/j.canrad.2026.104798","url":null,"abstract":"","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104798"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146215409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management and work-up procedures of patients with head and neck malignancies treated by radiation: 2025 update","authors":"Marion Tonneau ,&nbsp;Yoann Pointreau ,&nbsp;Pierre Blanchard ,&nbsp;Laure Vieillevigne ,&nbsp;Guillaume Janoray ,&nbsp;Vincent Grégoire","doi":"10.1016/j.canrad.2026.104803","DOIUrl":"10.1016/j.canrad.2026.104803","url":null,"abstract":"<div><div>Radiotherapy alone or in association with systemic treatment plays a major role in the treatment of head and neck tumours, either as a primary treatment or as a postoperative modality. The management of these tumours is multidisciplinary, requiring particular care at every treatment step. We present the 2025 update of the recommendations of the Société française de radiothérapie oncologique (the French society for radiation oncology) on the radiotherapy of head and neck tumours from the imaging work-up needed for optimal selection of treatment volume, to optimization of the dose distribution and delivery.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104803"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147350072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Chemoimmunotherapy for localized non-small cell lung cancer: A new standard for all stage III?","authors":"Étienne Martin ,&nbsp;Courèche Kaderbhai ,&nbsp;Flore Bonnet ,&nbsp;Cédric Chevalier ,&nbsp;Manou Rakotosamimanana ,&nbsp;Claudia Pouypoudat ,&nbsp;Jérémy Baude","doi":"10.1016/j.canrad.2026.104806","DOIUrl":"10.1016/j.canrad.2026.104806","url":null,"abstract":"<div><div>The management of stage III non-small-cell lung cancers represents a therapeutic challenge due to their heterogeneity, requiring a multimodal approach. The definition of resectability is a crucial point in guiding the optimal treatment strategy. In patients with resectable disease and no oncogenic driver alterations, neoadjuvant chemoimmunotherapy before surgery has emerged as a new standard, providing significant improvements in pathological response, event-free survival and overall survival, compared to chemotherapy alone. These excellent results prompt consideration of chemoimmunotherapy in patients with potentially resectable or unresectable disease, particularly in combination with chemoradiotherapy. This article provides a comprehensive review of the literature regarding the role of chemoimmunotherapy in stage III non-small cell lung cancers, whether resectable, potentially resectable or unresectable.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104806"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147747155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiotherapy needs in French-speaking low- and middle-income countries: Overcoming language barriers for equitable cancer care","authors":"Philippe Harris ,&nbsp;Marc Gaudet ,&nbsp;Lilia Naoun ,&nbsp;Jean-Philippe Pignol ,&nbsp;Maroie Barkati ,&nbsp;Marjory Jolicœur ,&nbsp;Yolande Lievens ,&nbsp;May Abdel-Wahab ,&nbsp;Jean-Marc Bourque","doi":"10.1016/j.canrad.2026.104801","DOIUrl":"10.1016/j.canrad.2026.104801","url":null,"abstract":"<div><h3>Purpose</h3><div>Cancer impacts populations in low- and middle-income countries disproportionately, where resources are limited, and cancer often diagnosed at more advanced stages. Radiotherapy plays a crucial role in treatment of cancer. However, language barriers often hinder partnerships and training with certain low- and middle-income countries, as most scientific societies primarily operate in English. This project aimed to evaluate the current, projected needs and gaps in radiotherapy specific to French-speaking low- and middle-income countries.</div></div><div><h3>Materials and methods</h3><div>An infrastructure database of 89 French-speaking countries was compiled, including countries associated with the Organisation internationale de la francophonie. Cross-referencing with World Bank income groups identified French-speaking low- and middle-income countries. Available radiotherapy infrastructures were obtained from the International Atomic Energy Agency. Projections for cancer cases and radiation therapy needs were made for 2030 and 2040.</div></div><div><h3>Results</h3><div>Thirty-five countries were identified as French-speaking low- and middle-income countries. Projected cancer burden is expected to increase by 44.7 % between 2020 and 2040. Assuming a conservative 50 % of patients benefit from radiotherapy, demand for treatment units will increase of 34.8 % between 2020 and 2040. The average number of radiotherapy units per 1000 cases remained low at 1.0 among countries with radiotherapy; significantly below the targeted two units per 1000 cases. Fourteen French-speaking low- and middle-income countries had no radiation capacity.</div></div><div><h3>Conclusion</h3><div>French-speaking low- and middle-income countries have a significant shortage of radiotherapy infrastructure for the increasing cancer demand. Limited language diversity in educational resources poses a barrier to radiotherapy access in these settings. This linguistic barrier may exacerbate workforce shortages in radiotherapy. Global initiatives should prioritize language considerations when strategizing efforts and allocating resources. High-income French-speaking nations are strategically well placed to cultivate collaborative networks essential for the advancement of these initiatives.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104801"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146776994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiotherapy for liver tumours⭑","authors":"Marin Guigo ,&nbsp;Laure Parent ,&nbsp;Nicolas Jaksic ,&nbsp;Olivier Riou ,&nbsp;Véronique Vendrely ,&nbsp;Emmanuel Rio","doi":"10.1016/j.canrad.2026.104802","DOIUrl":"10.1016/j.canrad.2026.104802","url":null,"abstract":"<div><div>Radiotherapy for hepatic tumours has evolved from palliative care to a potentially curative approach, thanks to advancements like stereotactic body radiotherapy. This technique allows for precise targeting while sparing healthy liver tissue, making it an option for hepatocellular carcinoma and liver metastases when surgery or ablation are contraindicated, achieving high response rates. Additionally, combined approaches such as stereotactic body radiotherapy following transarterial chemoembolization improve tumour response. Emerging modalities like magnetic resonance imaging-guided adaptive radiotherapy and proton beam therapy offer further precision, enhancing outcomes and reducing toxicity. Ongoing studies aim to refine treatment strategies and validate these advances.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104802"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Image-guided radiotherapy: From prepositionning to treatment delivery","authors":"Renaud de Crevoisier ,&nbsp;Caroline Lafond ,&nbsp;Igor Bessières ,&nbsp;Anaïs Barateau ,&nbsp;Coralie Hulot ,&nbsp;Igor Latorzeff ,&nbsp;Kévin Quintin ,&nbsp;Joël Castelli ,&nbsp;Grégory Delpon","doi":"10.1016/j.canrad.2026.104804","DOIUrl":"10.1016/j.canrad.2026.104804","url":null,"abstract":"<div><div>We present the updated recommendations of the Société française de radiothérapie oncologique (the French society for oncology radiotherapy) on image-guided radiotherapy. The objective of image-guided radiotherapy is to account for anatomical variations of the target volume occurring between or during the irradiation fractions, such as displacements and/or deformations, so that the delivered dose corresponds to the planned dose or could be even improved. This article presents the different image-guided radiotherapy devices, their clinical use, associated quality control procedures, and quantifies the possible additional dose generated by each of them. The practical implementation of image-guided radiotherapy across various tumour sites is summarized, based on the different “RecoRad™” guideline articles. Adaptive radiotherapy strategies are then detailed, due to its complexity and its recent development. The role of radiation technologist in the practice of image-guided radiotherapy is also specified. Finally, a brief update is provided on the issue of the additional dose associated with the in-room ionizing imaging, which must be estimated.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"30 1","pages":"Article 104804"},"PeriodicalIF":1.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147517557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}